Innate Response Activator B Cells Protect Against Microbial Sepsis
Author(s) -
Philipp J. Rauch,
Aleksey Chudnovskiy,
Clinton S. Robbins,
Georg F. Weber,
Martin Etzrodt,
Ingo Hilgendorf,
Elizabeth Tiglao,
JoseLuiz Figueiredo,
Yoshiko Iwamoto,
Igor Theurl,
Rostic Gorbatov,
Michael T. Waring,
Adam Chicoine,
Majd Mouded,
Mikaël J. Pittet,
Matthias Nahrendorf,
Ralph Weissleder,
Filip K. Świrski
Publication year - 2012
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.1215173
Subject(s) - innate immune system , biology , immunology , sepsis , effector , immunity , population , receptor , microbiology and biotechnology , immune system , medicine , genetics , environmental health
Recognition and clearance of a bacterial infection are a fundamental properties of innate immunity. Here, we describe an effector B cell population that protects against microbial sepsis. Innate response activator (IRA) B cells are phenotypically and functionally distinct, develop and diverge from B1a B cells, depend on pattern-recognition receptors, and produce granulocyte-macrophage colony-stimulating factor. Specific deletion of IRA B cell activity impairs bacterial clearance, elicits a cytokine storm, and precipitates septic shock. These observations enrich our understanding of innate immunity, position IRA B cells as gatekeepers of bacterial infection, and identify new treatment avenues for infectious diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom